$The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours$

The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours

Background: The aim of this prospective observational study was to evaluate the dosimetry benefits, changes in pulmonary function, and clinical outcome of online adaptive MR-guided SBRT. Methods: From 11/2020–07/2022, 45 consecutive patients with 59 lesions underwent multi-fraction SBRT (3–8 fractio...

Full description

Bibliographic Details
Main Authors:	Svenja Hering, Alexander Nieto, Sebastian Marschner, Jan Hofmaier, Nina-Sophie Schmidt-Hegemann, Vanessa da Silva Mendes, Guillaume Landry, Maximilian Niyazi, Farkhad Manapov, Claus Belka, Stefanie Corradini, Chukwuka Eze
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Clinical and Translational Radiation Oncology
Subjects:	MR-guided radiotherapy Lung cancer Radiation oncology MR-guided SBRT MR-guided SABR MR-Linac, SBRT, SABR, lung metastases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630824000132

Similar Items

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
by: Tomas M. Janssen, et al.
Published: (2022-06-01)

Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors
by: Paul Rogowski, et al.
Published: (2021-03-01)

Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
by: Lorraine Portelance, et al.
Published: (2021-08-01)

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
by: P. Hoegen, et al.
Published: (2022-03-01)

Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR
by: Jong Min Park, et al.
Published: (2019-06-01)

Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences
by: L.G. Merckel, et al.
Published: (2024-03-01)

Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results
by: Maria L. Sandoval, et al.
Published: (2021-07-01)

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia
by: Berend J. Slotman, et al.
Published: (2022-08-01)

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy
by: Matthew D. Hall, et al.
Published: (2023-01-01)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
by: Fabian Weykamp, et al.
Published: (2022-12-01)

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
by: Famke L. Schneiders, et al.
Published: (2023-11-01)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
by: Tobias Finazzi, et al.
Published: (2020-04-01)

Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator
by: Jinzhong Yang, et al.
Published: (2021-01-01)

Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy
by: Janita E. van Timmeren, et al.
Published: (2021-01-01)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
by: A. Mitchell, et al.
Published: (2022-07-01)

Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists
by: Marnix J.A. Rasing, et al.
Published: (2022-09-01)

MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System
by: Teo Stanescu, et al.
Published: (2022-01-01)

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
by: J. Ristau, et al.
Published: (2022-04-01)

MR-Guided Adaptive Radiotherapy for Bladder Cancer
by: Adham Hijab, et al.
Published: (2021-02-01)

1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
by: Francesco Cuccia, et al.
Published: (2022-04-01)

MR-Guided Radiotherapy for Prostate Cancer
by: Boris R. Tocco, et al.
Published: (2020-12-01)

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
by: J. Schaule, et al.
Published: (2021-09-01)

Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy
by: Yadav Poonam, et al.
Published: (2019-09-01)

1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation
by: Pierluigi Bonomo, et al.
Published: (2021-01-01)

Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach
by: Amit Gupta, et al.
Published: (2022-01-01)

Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac
by: Moritz Rabe, et al.
Published: (2024-03-01)

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
by: A. Hunt, et al.
Published: (2020-11-01)

MR-guided stereotactic radiation therapy for head and neck cancers
by: He Wang, et al.
Published: (2024-05-01)

MR-guidance in clinical reality: current treatment challenges and future perspectives
by: S. Corradini, et al.
Published: (2019-06-01)

Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy
by: Doris N. Rusu, et al.
Published: (2023-12-01)

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
by: Sebastian Regnery, et al.
Published: (2022-05-01)

Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience
by: Helena Isabel Garcia Schüler, et al.
Published: (2021-11-01)

Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer
by: Mireille Conrad, et al.
Published: (2023-05-01)

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
by: Jennifer Dang, et al.
Published: (2022-09-01)

Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
by: Vanessa Da Silva Mendes, et al.
Published: (2021-07-01)

First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac
by: Daniel Wegener, et al.
Published: (2022-08-01)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
by: Miguel A. Palacios, et al.
Published: (2022-10-01)

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
by: Sydney Wolfe, et al.
Published: (2023-09-01)

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
by: Jonathan Mohajer, et al.
Published: (2021-01-01)

Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy
by: Mutlay Sayan, et al.
Published: (2020-09-01)